According to a new report from Intel Market Research, the global Continuous Glucose Monitoring (CGM) Devices market was valued at USD 6.53 billion in 2025 and is projected to reach USD 15.87 billion by 2034, growing at a robust CAGR of 10.2 % during the forecast period (2026–2034). This growth is propelled by the expanding global diabetes burden, rapid technological innovations in sensor...

According to a new report from Intel Market Research, the Europe Continuous Glucose Monitoring (CGM) Devices market was valued at USD 1.96 billion in 2025 and is projected to reach USD 4.76 billion by 2034, growing at a robust CAGR of 10·3% during the forecast period (2026–2034). This growth is propelled by the accelerating prevalence of diabetes across Europe, continuous...

The North America Continuous Glucose Monitoring Device (CGMD) Market is experiencing remarkable expansion as diabetes prevalence continues to rise and healthcare providers increasingly adopt real-time glucose monitoring technologies. Continuous glucose monitoring devices enable patients and clinicians to track glucose levels throughout the day and night, providing actionable insights that...

The North America Continuous Glucose Monitoring Device (CGMD) Market is experiencing remarkable expansion as diabetes prevalence continues to rise and healthcare providers increasingly adopt real-time glucose monitoring technologies. Continuous glucose monitoring devices enable patients and clinicians to track glucose levels throughout the day and night, providing actionable insights that...

According to a new report from Intel Market Research, the global Biosensor Semiconductor market was valued at USD 4.12 billion in 2025 and is projected to reach USD 8.73 billion by 2034, growing at a robust CAGR of 7.3% during the forecast period (2026–2034). This expansion is driven by the accelerating demand for point‑of‑care diagnostics, the rise of wearable health‑monitoring devices,...